SI
SI
discoversearch

Biotech / Medical
Neptune Technologies & Bioressources Inc. - NTB.V
An SI Board Since July 2011
Posts SubjectMarks Bans Symbol
408 13 0 NEPT
Emcee:  Sultan Type:  Unmoderated
Neptune Wellness Solutions researches, develops and commercializes proprietary bioactive
ingredients and products with the goal of superior added-value and clinically proven health benefits. The
Company extracts a range of bioactive ingredients such as novel proprietary omega-3 phospholipids from
abundant yet underexploited marine biomass including Krill, a cold deep water zooplankton. Neptune’s
first commercially available product is Neptune Krill Oil (NKO®), which represents marine based omega-3
phospholipids with potential in cardiovascular, cognitive and anti-inflammatory disorders. Neptune is pursuing
market opportunities in the nutraceutical market including dietary supplements and functional foods. The
Company is also pursuing opportunities in the pharmaceutical market through its pharmaceutical subsidiaries,Acasti and NeuroBioPharm (including medical food, over-the-counter and prescription drug applications).

neptunecorp.com

NOTE: Neptune trades on Toronto.. For Canadian & US quote, enter NEPT

Acasti Pharma Inc. is 35% owned by Neptune.. For Canadian & US quote, enter ACST

acastipharma.com
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
408More buys by Mr. Moretz m.canadianinsider.comSultan-August 31
407More Insider Buys .. canadianinsider.comSultan-August 24
406Another insider, Mr. Schottenfeld, Director added 49k shares.. Before this buy, Sultan-August 23
405Another insider, CFO added 25k shares. So now he owns directly 150k shares.. HaSultan-August 22
404Of note however, is purchase by John Morris Moretz, new Chairman of the Board ofSultan-August 20
403Couple of items of note today, August 17th.. NEPT was up nearly 17%, avg. voluSultan-August 18
402Acasti Pharma Announces the Election of Its Directors, Changes to Its Stock OptiSultan-August 17
401Neptune Technologies & Bioresources' (NEPT) CEO Jim Hamilton on Q1 2018 Sultan-August 16
400Neptune Announces First Quarter Results finance.yahoo.com Acasti Pharma ReporSultan-August 14
399Vic Neufeld aphria.ca The company also have US and Florida specific websites Sultan-August 9
398Were a POT company now. I actually like the potential market growth better now.E_K_S-August 9
397Shareholder samples perhaps? Beyond krill, Neptune will focus on the growing caCusterInvestor-August 9
396Aker Acquires Neptune’s Krill Business, Neptune Focuses on Other Ventures naturSultan-August 9
395Market is not too positive of the COB leaving but maybe he was causing the compaE_K_S-August 8
394Aker BioMarine and Neptune Announce Closing of $US34 Million Transaction to AcceSultan-August 8
393NEPT and ACST on BNN bnn.caSultan-August 2
392Indicators show bullish crossover in MACD and Stochastic oscillators. [graphic]hollyhunter-July 7
391Acasti Pharma June Presentation by the CEO .. runs 1.23 hr Registration requireSultan-June 22
390Acasti will be presenting at BIO International Convention 2017, San Diego June 1Sultan-June 15
389Extract from the CC Transcript Considering how cannabis stocks have fared, NEPSultan-June 10
388Neptune Announces 4-Month Period and 13-Month Period Results finance.yahoo.com Sultan-June 8
387Acasti Pharma and CordenPharma Announce Large Scale Production of CaPre® wiSultan-June 2
386Neptune to Hold Conference Call to Discuss Fourth Quarter and Fiscal Year-End ReSultan-May 18
385Acasti Pharma Presents CaPre Clinical Data at National Lipid Association ScientiSultan-May 18
384Neptune Technologies & Bioresources: Unique Medical Cannabis Partnership AnnSultan-May 16
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2017 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.